[ad_1]
San Francisco, February 23, 2024(BUSINESS WIRE)–Vir Biotechnology, Inc. (NASDAQ: VIR) today announced that management will participate in the following upcoming investor meetings in March:
-
TD Cowen’s 44th Annual Healthcare Conference was held at the Boston Marriott Copley Plaza. Marianne De Backer, MS, PhD, MBA, CEO, is scheduled to participate in a fireside chat on Monday, March 4 at 2:50 pm ET/11:50 am PT.
-
The Leerink Partners Global Biopharmaceutical Conference was held at the Fontainebleau Hotel in Miami Beach. Vir management will host one-on-one investor meetings on Monday, March 11 and Tuesday, March 12.
-
Barclays’ 26th Annual Global Healthcare Conference was held at the Loews Miami Beach Hotel in Miami. Marianne De Backer, MS, PhD, MBA, CEO, is scheduled to participate in a fireside chat on Tuesday, March 12 at 7:30 AM ET/4:30 AM PT.
The live webcast of the Fireside Chat can be viewed under Events & Presentations in the Investors section of Vir’s website at www.vir.bio and will be archived there for 30 days.
About Vir Biotech
Vir Biotechnology, Inc. is an immunology company dedicated to changing lives by strengthening the immune system to treat and prevent infectious diseases and other serious illnesses, including viral-related diseases. Vir has assembled two technology platforms designed to modulate the immune system by leveraging key observations of natural immune processes. Its current clinical development pipeline includes product candidates targeting hepatitis D, hepatitis B virus and human immunodeficiency virus. Vir has multiple preclinical drug candidates in development, including candidates targeting influenza A and B, COVID-19, RSV/MPV and HPV. Vir frequently posts information on its website that may be important to investors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220184688/en/
contact method
Carly has expired
Senior Director of Media Relations
cscaduto@vir.bio
+1-314-368-5189
investor
Richard Lepke
Senior Director of Investor Relations
rlepke@vir.bio
+1 978-973-9986
[ad_2]
Source link